冰毒-
甲基苯丙胺
医学
精神科
药物治疗
药物滥用
临床试验
重症监护医学
内科学
单体
有机化学
化学
聚合物
丙烯酸酯
出处
期刊:Current Neuropharmacology
[Bentham Science]
日期:2021-12-01
卷期号:19 (12): 2077-2091
被引量:22
标识
DOI:10.2174/1570159x19666210803091637
摘要
Almost two decades have passed since the last methamphetamine (METH) abuse epidemic. In recent years, METH abuse in the United States has been rapidly increasing and is currently one of the leading causes of death in our country. Available statistical data indicates reemergence of METH popularity and suggest an impending third epidemic of METH abuse. Alarmingly, there is no FDA-approved medication for METH use disorder (MUD). This disorder is currently treated with behavioral therapies; however, these therapies have limitations and would benefit from the addition of a MUD pharmacotherapy. Unfortunately, clinical trials have not yet found consistently effective pharmacotherapy for MUD. This review outlines the history of METH use, provides information on current prevalence of METH abuse and MUD, describes medications that have been in clinical trials for MUD, and addresses current as well as potential new treatments for MUD.
科研通智能强力驱动
Strongly Powered by AbleSci AI